Peridex and Ejection fraction decreased - a phase IV clinical study of FDA data

Summary:

Ejection fraction decreased is reported as a side effect among people who take Peridex (chlorhexidine gluconate), especially for people who are 50-59 old, also take Zometa, and have Multiple myeloma.

The phase IV clinical study analyzes which people have Ejection fraction decreased when taking Peridex. It is created by eHealthMe based on reports of 2,787 people who have side effects when taking Peridex from the FDA, and is updated regularly.

What is Peridex?

Peridex has active ingredients of chlorhexidine gluconate. eHealthMe is studying from 2,803 Peridex users. Check the latest studies of Peridex.

What is Ejection fraction decreased?

Ejection fraction decreased (systolic heart failure) is found to be associated with 1,062 drugs and 1,255 conditions by eHealthMe. Check the latest studies of Ejection fraction decreased.

On Aug, 06, 2026

2,787 people reported to have side effects when taking Peridex.
Among them, 38 people (1.36%) have Ejection fraction decreased.

$Could Peridex cause Ejection fraction decreased?$

Among these 38 people:

What is the age of people who have Ejection fraction decreased when taking Peridex? *

What are other drugs people take besides Peridex? *

What are other side effects people have besides Ejection fraction decreased? *

Fatigue (feeling of tiredness): 28 people, 73.68%
Pain: 27 people, 71.05%
Osteonecrosis Of Jaw (death of bone of jaw): 27 people, 71.05%
Osteomyelitis (infection of bone): 27 people, 71.05%
Hypotension (abnormally low blood pressure): 24 people, 63.16%
Injury: 23 people, 60.53%
Stress And Anxiety: 22 people, 57.89%
Acute Kidney Failure: 21 people, 55.26%
Thrombocytopenia (decrease of platelets in blood): 21 people, 55.26%
Osteoarthritis (a joint disease caused by cartilage loss in a joint): 20 people, 52.63%

What are the existing conditions these people have? *

Multiple Myeloma (cancer of the plasma cells): 7 people, 18.42%
Eczema (patches of skin become rough and inflamed, with itching and bleeding blisters): 6 people, 15.79%
Oral Disorder (mouth disease): 5 people, 13.16%
Metastases To Bone (cancer spreads to bone): 4 people, 10.53%
Bone Marrow Conditioning Regimen: 3 people, 7.89%
Pulmonary Embolism (blockage of the main artery of the lung): 3 people, 7.89%
Non-Hodgkin's Lymphoma Unspecified Histology Indolent (malignant (cancer) cells form in the lymph system- unspecified histology indolent): 3 people, 7.89%
Neoplasm Malignant (cancer tumour): 2 people, 5.26%
Colitis (inflammation of colon): 2 people, 5.26%
Pain: 2 people, 5.26%

* Approximation only. Some reports may have incomplete information.

Do you take Peridex and have Ejection fraction decreased?

- Check whether Ejection fraction decreased is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Peridex:

Peridex (2,803 reports)

Browse all side effects of Peridex:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Ejection fraction decreased:

Ejection fraction decreased (1,062 drugs)

Browse all the conditions that are associated with Ejection fraction decreased:

Ejection fraction decreased (1,255 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on chlorhexidine gluconate (the active ingredients of Peridex) and Peridex (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.